Xenetic Biosciences, Inc. Strengthens Scientific Advisory Board with Two Key Appointments Jul 30, 2020
Xenetic Biosciences, Inc. Provides Development Update for Its Personalized CAR T Platform Technology, XCART(TM) Jul 1, 2020
Xenetic Biosciences, Inc. Announces Collaboration with Pharmsynthez and Multiple Academic Institutions in Russia and Belarus to Advance Development of XCART(TM) Platform Jun 16, 2020
Xenetic Biosciences, Inc. Announces Research and Development Collaboration with Scripps Research to Advance XCART(TM) Platform May 19, 2020
Xenetic Biosciences, Inc. Reports First Quarter 2020 Financial Results and Provides Corporate Update May 14, 2020
Xenetic Biosciences' Webcast Replay from Noble Capital Markets' 16th Annual Investor Conference Presentation Now Available Feb 27, 2020
Xenetic Biosciences, Inc. Appoints Accomplished Biopharmaceutical Executive, Greg MacMichael, Ph.D. to Scientific Advisory Board Feb 26, 2020
